Heterozygous p53-deficient mice are not susceptible to 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) carcinogenicity

Cancer Letters

Volumn 139, Issue 2, 1999, Pages 177-182

  Park, Cheol Beom ^a   Kim, Dae Joong ^b   Uehara, Nobuaki ^a   Takasuka, Nobuo ^a   Hiroyasu, Baba Toriyama ^a   Tsuda, Hiroyuki ^a  

^a NATIONAL CANCER CENTER   (Japan)

^b National Institute of Toxicological Research   (South Korea)

Author keywords

2 Amino 3,8 dimethylimidazo 4,5 f quinoxaline (MeIQx); p53 Heterozygote mice; Susceptibility

Indexed keywords

2 AMINO 3,8 DIMETHYLIMIDAZO[4,5 F]QUINOXALINE; PROTEIN P53;

ANGIOSARCOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER CARCINOGENESIS; CANCER RESEARCH; CARCINOGENICITY; CONTROLLED STUDY; FEMALE; GENE MUTATION; HETEROZYGOTE; LIVER CANCER; LUNG ADENOMA; LYMPHOMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY;

ALLELES; ANIMALS; BODY WEIGHT; CARCINOGENS; COCARCINOGENESIS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENES, P53; HEMATOLOGIC NEOPLASMS; HETEROZYGOTE; LIVER NEOPLASMS, EXPERIMENTAL; LUNG NEOPLASMS; MALE; MICE; MICE, KNOCKOUT; MUTAGENS; NEOPLASMS, EXPERIMENTAL; QUINOLINES; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032946248     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(99)00036-1     Document Type: Article

References (37)

1. Donehower L.A., Harvey M., Slagle B.L., McArthur M.J., Montgomery C.A. Jr., Butel J.S., Bradley A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. Nature. 356:1992;215-221.
2. Hursting S.D., Perkins S.N., Buzard G.S., Haines D.C., Phang J.M. Susceptibility of hemizygous p53-knockout mice to nitrosomethylurea-induced lymphoma development (Meeting abstract). Proc. Annu. Meet. Am. Assoc. Cancer Res. 37:1996;A741.
3. Hursting S.D., Perkins S.N., Haines D.C., Ward J.M., Phang J.M. Chemoprevention of spontaneous tumorigenesis in p53-knockout mice. Cancer Res. 55:1995;3949-3953.
4. Harvey M., McArthur M.J., Montgomery C.A. Jr., Butel J.S., Bradley A., Donehower L.A. Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice. Nat. Genet. 5:1993;225-229.
5. Kemp C.J., Wheldon T., Balmain A. P53-deficient mice are extremely susceptible to radiation-induced tumorigenesis. Nat. Genet. 8:1994;66-69.
6. Dunnick J.K., Hardisty J.F., Herbert R.A., Seely J.C., Furedi-Machacek M., Foley J.F., Lacks G.D., Stasiewicz S., French J.E. Phenolphthalein induces thymic lymphomas accompanied by loss of the p53 wild type allele in heterozygous p53-deficient mice. Toxicol. Pathol. 25:1997;533-540.
7. Ozaki K., Sukata T., Yamamoto S., Uwagawa S., Seki T., Kawasaki H., Yoshitake A., Wanibuchi H., Koide A., Mori Y., Fukushima S. High susceptibility of p53(+/-) knockout mice in N-butyl-N-(4-hydroxybutyl)nitrosamine urinary bladder carcinogenesis and lack of frequent mutation in residual allele. Cancer Res. 58:1998;3806-3811.
8. Skog K. Cooking procedures and food mutagens: A literature review. Food Chem. Toxicol. 31:1993;655-675.
9. Matsukura N., Kawachi T., Morino K., Ohgaki H., Sugimura T., Takayama S. Carcinogenicity in mice of mutagenic compounds from a tryptophan pyrolyzate. Science. 213:1981;346-347.
10. Snyderwine E.G., Turesky R.J., Turteltaub K.W., Davis C.D., Sadrieh N., Schutt H.A., Nagao M., Sugimura T., Thorgeirsson U.P., Adamson R.H., Thorgeirsson S.S. Metabolism of food-derived heterocyclic amines in nonhuman primates. Mutat. Res. 376:1997;203-210.
11. Kato T., Ohgaki H., Hasegawa H., Sato S., Takayama S., Sigmura T. Carcinogenicity in rats of a mutagenic compound, 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline. Carcinogenesis. 9:1988;71-73.
12. Ohgaki H., Hasegawa H., Suenaga M., Sato S., Takayama S., Sugimura T. Carcinogenicity in mice of a mutagenic compound, 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) from cooked foods. Carcinogenesis. 8:1987;665-668.
13. Okonogi H., Ushijima T., Shimizu H., Sugimura T., Nagao M. Induction of aberrant crypt foci in C57BL/6N mice by 2-amino-9H-pyrido[2,3-b]indole (A alpha C) and 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx). Cancer Lett. 111:1997;105-109.
14. Ito N., Hasegawa R., Sano M., Tamano S., Esumi H., Takayama S., Sugimura T. A new colon and mammary carcinogen in cooked food, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). Carcinogenesis. 12:1991;1503-1506.
15. Ghoshal A., Preisegger K.H., Thorgeirsson S.S., Snyderwine E.G. Induction of mammary tumors in female Sprague-Dawley rats by the food-derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and effect of dietary fat. Carcinogenesis. 15:1994;2429-2433.
16. Ohgaki H., Kusama K., Matsukura N., Morino K., Hasegawa H., Sato S., Takayama S., Sugimura T. Carcinogenicity in mice of a mutagenic compound, 2-amino-3-methylimidazo[4,5-F]quinoline, from broiled sardine, cooked beef and beef extract. Carcinogenesis. 5:1984;921-924.
17. Takayama S., Nakatsuru Y., Masuda M., Ohgaki H., Sato S., Sugimura T. Demonstration of carcinogenicity in F344 rats of 2-amino-3methyl-imidazo[4,5-F]quinoline from broiled sardine, fried beef and beef extract. Gann. 75:1984;467-470.
18. Felton J.S., Malfatti M.A., Knize M.G., Salmon C.P., Hopmans E.C., Wu R.W. Health risks of heterocyclic amines. Mutat. Res. 376:1997;37-41.
19. Ushiyama T., Makino H., Kakiuchi H., Inoue R., Sugimura T., Nagao M. Presence of carcinogenic heterocyclic amines in urine of healthy volunteers eating normal diet, but not of inpatients receiving parenteral alimentation. Carcinogenesis. 12:1991;1417-1422.
20. Wakabayashi K., Ushiyama H., Takahashi M., Nukaya H., Kim S.-B., Hirose M., Ochiai M., Sugimura T., Nagao M. Exposure to heterocyclic amines. Environ. Health Perspect. 99:1993;129-134.
21. Aguustsson K., Skog K., Jagerstad M., Steineck G. Assessment of the human exposure to heterocyclic amines. Carcinogenesis. 18:1997;1931-1935.
22. Wakabayashi K., Totsuka Y., Fukutome K., Oguri A., Ushiyama H., Sugimura T. Human exposure to mutagenic/carcinogenic heterocyclic amines and comutagenic beta-carbolines. Mutat. Res. 376:1997;253-259.
23. Knize M.G., Cunningham P.L., Avila J.R., Jones A.L., Griffin E.A., Felton J.S. Formation of mutagenic activity from amino acids heated at cooking temperatures. Food Chem. Toxicol. 32:1994;55-60.
24. Wakabayashi K., Nagao M., Esumi H., Sugimura T. Food-derived mutagens and carcinogens. Cancer Res. 52:1992;2092-2098.
25. Dass S.B., Hammons G.J., Bucci T.J., Heflich R.H., Casciano D.A. Susceptibility of C57BL/6 mice to tumorigenicity induced by dimethylnitrosamine and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in the neonatal bioassay. Cancer Lett. 124:1998;105-110.
26. Kemp C., Donehower L.A., Bradley A., Balmain A. Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors. Cell. 74:1993;813-822.
27. Burn P.A., J Kemp C., Gannon J.V., Lane D.P., Bremner R., Balmain A. Loss of heterozygosity and mutational alterations of the p53 gene in skin tumours of interspecific hybrid mice. Oncogene. 6:1991;2363-2369.
28. Donehower L.A., Godley L.A., Aldaz M., Pyle R., Shi Y.P., Pinkel D., Gray J., Bradley A., Medina D., Varmus H.E. Deficiency of p53 accelerates mammary tumorigenesis in Wnt-1 transgenic mice and promotes chromosomal instability. Genes Dev. 9:1995;882-895.
29. Kuwashima Y., Kurosumi M., Kobayashi Y., Tanuma J., Suemasu K., Higashi Y., Kasamatsu T., Shiromizu K., Kishi K. Random nuclear p53 overexpression pattern in tamoxifen-mediated endometrial carcinoma. Int. J. Gynecol. Pathol. 17:1998;135-139.
30. Nelson W.G., Kastan M.B. DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways. Mol. Cell. Biol. 14:1994;1815-1823.
31. Hirose M., Wakabayashi K., Ochiai M., Kushida H., Sato H., Sugimura T., Nagao M. Formation and removal of DNA adducts in the liver of rats chronically fed the food-borne carcinogen, 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline. Jpn. J. Cancer Res. 86:1995;516-522.
32. Turteltaub K.W., Mauthe R.J., Dingley K.H., Vogel J.S., Garner C.E., Frantz R.C., Shen N. MeIQx-DNA adduct formation in rodent and human tissues at low doses. Mutat. Res. 376:1997;243-252.
33. Makino H., Ishizaka Y., Tsujimoto A., Nakamura T., Onda M., Sugimura T., Nagao M. Rat p53 gene mutations in primary Zymbal gland tumors induced by 2-amino-3-methylimidazo[4,5-f]quinoline, a food mutagen. Proc. Natl. Acad. Sci. USA. 89:1992;4850-4854.
34. Ushijima T., Makino H., Kakiuchi H., Inoue R., Sugimura T., Nagao M. Genetic alterations in HCA-induced tumors. Princess Takamatsu Symp. 23:1995;281-291.
35. Makino H., Ushijima T., Kakiuchi H., Onda M., Ito N., Sugimura T., Nagao M. Absence of p53 mutations in rat colon tumors induced by 2-amino-6-methyldipyrido[1,2-a:3′,2′-d]imidazole, 2-amino-3-methylimidazo[4,5-f]quinoline, or 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Jpn. J. Cancer Res. 85:1994;510-514.
36. Yamamoto S., Mitsumori K., Kodama Y., Matsunuma N., Manabe S., Okamiya H., Suzuki H., Fukuda T., Sakamaki Y., Sunaga M., Nomura G., Hioki K., Wakana S., Nomura T., Hayashi Y. Rapid induction of more malignant tumors by various genotoxic carcinogens in transgenic mice harboring a human prototype c-Ha-ras gene than non-transgenic mice. Carcinogenesis. 17:1996;2455-2461.
37. Murakami H., Sanderson N.D., Nagy P., Marino P.A., Merlino G., Thorgeirsson S.S. Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: Interaction of c-myc and transforming growth factor a in hepatic oncogenesis. Cancer Res. 53:1993;1719-1723.